Results 221 to 230 of about 2,332,572 (294)

Laryngeal Dysfunction Following COVID‐19: A TriNetX Retrospective Cohort Study

open access: yesThe Laryngoscope, EarlyView.
COVID‐19 is associated with an increased incidence of new‐onset laryngeal dysfunction, including chronic cough, dysphagia, voice disorders, vocal fold paralysis, and laryngeal spasm, compared with uninfected controls. Risk peaks one to two years after infection for most outcomes and is influenced by factors such as hospitalization, mechanical ...
Cali Loblundo   +4 more
wiley   +1 more source

Challenges in the Implementation of the Spanish Consensus on the Reduction of Oral Corticosteroids: Insights From the Medical Community. [PDF]

open access: yesOpen Respir Arch
Dominguez-Ortega J   +4 more
europepmc   +1 more source

Validity and Responsiveness of Chronic Rhinosinusitis Control Test Subdomains

open access: yesThe Laryngoscope, EarlyView.
The chronic rhinosinusitis control test (CRCT) is a psychometrically validated 8‐item patient‐reported outcome measure developed based on international consensus that measures, quantifies and classifies CRS control. The CRCT has two subdomains: a sinonasal subdomain and an impairment subdomain that measure distinct but complementary constructs related ...
Ahmad R. Sedaghat, Katie M. Phillips
wiley   +1 more source

Association Between Prednisone and Delayed Facial Nerve Palsy After Acoustic Neuroma Resection

open access: yesThe Laryngoscope, EarlyView.
Discharge with an oral prednisone taper was not associated with a reduced incidence of delayed facial nerve palsy following acoustic neuroma resection, even after rigorous adjustment for confounding using inverse probability weighting. The findings do not support routine prophylactic corticosteroid use for this indication.
Shahid Iqbal   +5 more
wiley   +1 more source

Pregabalin Efficacy in Treatment of Chronic Neurogenic Cough

open access: yesThe Laryngoscope, EarlyView.
The use of neuromodulators for chronic cough has increased; however, the choice of medication, dosing regimen, and duration are still unclear. This longitudinal study of 95 adults taking pregabalin, 75 mg twice daily, for CNC demonstrated 78% improvement or resolution of cough, 17% unchanged, 1% worse cough, with a mean of 6 weeks of therapy, and only ...
Jacqui Allen   +3 more
wiley   +1 more source

Intervention Outcomes for Meniere's Disease: An Umbrella Review

open access: yesThe Laryngoscope, EarlyView.
ABSTRACT Objective To assess and summarize the outcomes of major pharmacologic, device‐based, and surgical interventions reported in systematic reviews and meta‐analyses for the treatment of Meniere's disease. Data Sources CINAHL, Cochrane, PubMed, Scopus.
Warren B. Chun   +7 more
wiley   +1 more source

Taste Dysfunction and Bell's Palsy: A Scoping Review

open access: yesThe Laryngoscope, EarlyView.
Taste dysfunction is a well‐recognized but inconsistently reported symptom in Bell's palsy. This scoping review found that taste dysfunction is prevalent in these patients, often precedes facial weakness, and commonly improves within 6 months. Standardized, longitudinal studies employing validated psychophysical measures are needed to clarify the ...
Sherina R. Thomas   +2 more
wiley   +1 more source

Exocrine Gland Dysfunction in Parkinson's Disease: Pathophysiology, Clinical Manifestations, and Therapeutic Perspectives—A Narrative Review

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background Non‐motor symptoms, especially autonomic dysfunction, are major contributors to disability and decreased quality of life in Parkinson's disease (PD). Despite being common and having a wide range of clinical facets, exocrine gland dysfunction is still not well recognized and managed.
Renato P. Munhoz   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy